An individualized approach to glycemic control in type 2 diabetes reduced life expectancy due to an increase in complications, but patients had an increase in quality-adjusted life-years resulting from fewer hypoglycemic events and medications, compared with the uniform intensive control group, according to a study in the Annals of Internal Medicine. Researchers evaluated data from the National Health and Nutrition Examination Survey 2011 to 2012 and found that individualized control saved $13,547 per patient, compared with intensive control.
Research examines efficacy of individualized glycemic control in diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.